India, Oct. 14 -- Shares of Liquidia (LQDA) are surging 26% after the company reached a global settlement with United Therapeutics, resolving all six pending legal disputes and ensuring continued commercialization of YUTREPIA for pulmonary arterial hypertension (PAH).
The stock is currently trading at $33.74, up $6.93 or 25.85%, on the Nasdaq. It opened at $35.70 after closing the previous session at $26.81. The stock has traded between $21.94 and $93.61 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....